Discover investment opportunities in Robotic Surgery Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Robotic Surgery Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Robotic Surgery Stocks using our Smart AI Filter.
9 stocks found for "Robotic Surgery Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.36 Risk measure | ±21.7% Price volatility | 15.1 Valuation | 3.17% Annual yield | |||
0.64 Risk measure | ±28.2% Price volatility | 69.3 Valuation | 0.00% Annual yield | |||
0.83 Risk measure | ±27.4% Price volatility | 23.5 Valuation | 3.08% Annual yield | |||
0.70 Risk measure | ±21.9% Price volatility | 10.9 Valuation | 1.04% Annual yield | |||
0.89 Risk measure | ±29.3% Price volatility | 17.3 Valuation | 0.00% Annual yield | |||
0.41 Risk measure | ±18.7% Price volatility | 37.4 Valuation | 0.00% Annual yield | |||
0.37 Risk measure | ±19.7% Price volatility | 14.7 Valuation | 3.18% Annual yield | |||
1.22 Risk measure | ±57.6% Price volatility | 16.6 Valuation | 0.00% Annual yield | |||
0.51 Risk measure | ±20.1% Price volatility | 29.1 Valuation | 0.86% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Read moreZimmer Biomet eyes long-term gains with the $177M Monogram buyout, aiming to expand its robotic knee surgery offerings by 2027.
Read moreBesides Wall Street's top-and-bottom-line estimates for Intuitive Surgical (ISRG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Read moreGlobus Medical debuts DuraPro with Excelsius integration, boosting its Power Portfolio.
Read moreHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read moreMedtronic (MDT) closed the most recent trading day at $87.17, moving +1.34% from the previous trading session.
Read more